answering body |
Department of Health and Social Care |
|
|
question text |
To ask His Majesty's Government what assessment they have made of the findings of
the report by The Association of the British Pharmaceutical Industry False economy? How
NHS medicine procurement threatens the UK’s Life Sciences growth engine, published
on 23 February, that the continued current high rebate rates under the voluntary and
statutory schemes for branded medicines during the next five years would mean foregoing
£50 billion in GDP and £17.9 billion in tax revenues as a result of lost research
and development investment; and what are their estimates of the value of the potential
lost investment in this sector.
|
|